Trends in the Use of Opioids at the End of Life and the Expected Effects on Hastening Death

Journal of Pain and Symptom Management

Volumn 37, Issue 2, 2009, Pages 144-155

  Rurup, Mette L ^a   Borgsteede, Sander D ^a   van der Heide, Agnes ^b   van der Maas, Paul J ^b   Onwuteaka Philipsen, Bregje D ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

attitudes; cancer; end of life; intention; Morphine; opioids; oral morphine equivalent; pain; respiratory depression; trends

Indexed keywords

MORPHINE; OPIATE;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER PAIN; CARDIOVASCULAR DISEASE; DEATH; DISEASE COURSE; DRUG DOSE INCREASE; DRUG DOSE TITRATION; DRUG SAFETY; DRUG USE; EVIDENCE BASED PRACTICE; HUMAN; MAJOR CLINICAL STUDY; MEDICAL DECISION MAKING; MEDICAL SPECIALIST; MULTIVARIATE ANALYSIS; NEOPLASM; NETHERLANDS; NURSING HOME PERSONNEL; PAIN; PATIENT EDUCATION; PHYSICIAN; PHYSICIAN ATTITUDE; QUESTIONNAIRE; RESPIRATION DEPRESSION; TERMINAL CARE;

ADMINISTRATION, ORAL; ANALGESICS, OPIOID; ATTITUDE OF HEALTH PERSONNEL; DECISION MAKING; EUTHANASIA, ACTIVE; HUMANS; NETHERLANDS; PAIN; PHYSICIAN'S PRACTICE PATTERNS; PHYSICIANS; QUESTIONNAIRES; RISK ASSESSMENT; RISK FACTORS; SURVIVAL ANALYSIS; SURVIVAL RATE; TERMINAL CARE;

EID: 59649112828     PISSN: 08853924     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpainsymman.2008.02.010     Document Type: Article

References (35)

1. Potter J., Hami F., Bryan T., and Quigley C. Symptoms in 400 patients referred to palliative care services: prevalence and patterns. Palliat Med 17 (2003) 310-314
2. Teunissen S.C., Wesker W., Kruitwagen C., et al. Symptom prevalence in patients with incurable cancer: a systematic review. J Pain Symptom Manage 34 (2007) 94-104
3. Borgsteede S.D., Deliens L., Beentjes B., et al. Symptoms in patients receiving palliative care: a study on patient-physician encounters in general practice. Palliat Med 21 (2007) 417-423
4. Grossman S.A., Dunbar E.M., and Nesbit S.A. Cancer pain management in the 21st century. Oncology 20 (2006) 1333-1339
5. Enting R.H., Oldenmenger W.H., Van Gool A.R., van der Rijt C.C., and Sillevis Smitt P.A. The effects of analgesic prescription and patient adherence on pain in a Dutch outpatient cancer population. J Pain Symptom Manage 34 (2007) 523-531
6. Teno J.M., Clarridge B.R., Casey V., et al. Family perspectives on end-of-life care at the last place of care. JAMA 291 (2004) 88-93
7. McQuay H. Opioids in pain management. Lancet 353 (1999) 2229-2232
8. Estfan B., Mahmoud F., Shaheen P., et al. Respiratory function during parenteral opioid titration for cancer pain. Palliat Med 21 (2007) 81-86
9. Elliott T.E., and Elliott B.A. Physician attitudes and beliefs about use of morphine for cancer pain. J Pain Symptom Manage 7 (1992) 141-148
10. Whipple J.K., Lewis K.S., Quebbeman E.J., et al. Analysis of pain management in critically ill patients. Pharmacotherapy 15 (1995) 592-599
11. Hanks G.W., Conno F., Cherny N., et al. Morphine and alternative opioids in cancer pain: the EAPC recommendations. Expert Working Group of the Research Network of the European Association for Palliative Care. Br J Cancer 84 (2001) 587-593
12. Borgbjerg F.M., Nielsen K., and Franks J. Experimental pain stimulates respiration and attenuates morphine-induced respiratory depression: a controlled study in human volunteers. Pain 64 (1996) 123-128
13. 2 sensitivity after intravenous and epidural morphine in volunteers. Anesth Analg 62 (1983) 633-640
14. Hagle M.E., Lehr V.T., Brubakken K., and Shippee A. Respiratory depression in adult patients with intravenous patient-controlled analgesia. Orthop Nurs 23 (2004) 18-27
15. Macintyre P.E. Safety and efficacy of patient-controlled analgesia. Br J Anaesth 87 (2001) 36-46
16. Ko S., Goldstein D.H., and Van Den Kerkhof E.G. Definitions of "respiratory depression" with intrathecal morphine postoperative analgesia: a review of the literature. Can J Anaesth 50 (2003) 679-688
17. Thorns A., and Sykes N. Opioid use in last week of life and implications for end-of-life decision-making. Lancet 356 (2000) 398-399
18. Morita T., Tsunoda J., Inoue S., and Chihara S. Effects of high dose opioids and sedatives on survival in terminally ill cancer patients. J Pain Symptom Manage 21 (2001) 282-289
19. Sykes N., and Thorns A. The use of opioids and sedatives at the end of life. Lancet Oncol 4 (2003) 312-318
20. Bercovitch M., and Adunsky A. Patterns of high-dose morphine use in a home-care hospice service: should we be afraid of it?. Cancer 101 (2004) 1473-1477
21. Vitetta L., Kenner D., and Sali A. Sedation and analgesia-prescribing patterns in terminally ill patients at the end of life. Am J Hosp Palliat Care 22 (2005) 465-473
22. Good P.D., Ravenscroft P.J., and Cavenagh J. Effects of opioids and sedatives on survival in an Australian inpatient palliative care population. Intern Med J 35 (2005) 512-517
23. Seale C. National survey of end-of-life decisions made by UK medical practitioners. Palliat Med 20 (2006) 3-10
24. Bilsen J., Norup M., Deliens L., et al. Drugs used to alleviate symptoms with life shortening as a possible side effect: end-of-life care in six European countries. EURELD Consortium. J Pain Symptom Manage 31 (2006) 111-121
25. van der Heide A., Deliens L., Faisst K., et al. End-of-life decision-making in six European countries: descriptive study. EURELD Consortium. Lancet 362 (2003) 345-350
26. van der Heide A., Onwuteaka-Philipsen B.D., Rurup M.L., et al. End-of-life practices in The Netherlands under the Euthanasia Act. N Engl J Med 356 (2007) 1957-1965
27. Onwuteaka-Philipsen B.D., van der Heide A., Koper D., et al. Euthanasia and other end-of-life decisions in The Netherlands in 1990, 1995, and 2001. Lancet 362 (2003) 395-399
28. van der Maas P.J., van der Wal G., Haverkate I., et al. Euthanasia, physician-assisted suicide, and other medical practices involving the end of life in The Netherlands, 1990-1995. N Engl J Med 335 (1996) 1699-1705
29. In: Doyle D., Hanks G.W.C., and MacDonald N. (Eds). Oxford textbook of palliative medicine. 2nd ed. (1998), Oxford University Press, New York
30. Graeff A de, Hesselman GM, Krol RJA, et al. Palliative care: guidelines for practice. [Dutch] Utrecht: Association of Comprehensive Cancer Centres, 2006.
31. Hall S., Gallagher R.M., Gracely E., Knowlton C., and Wescules D. The terminal cancer patient: effects of age, gender, and primary tumor site on opioid dose. Pain Med 4 (2003) 125-134
32. Cepeda M.S., Farrar J.T., Baumgarten M., et al. Side effects of opioids during short-term administration: effect of age, gender, and race. Clin Pharmacol Ther 74 (2003) 102-112
33. Hartkopf Smith L.H. Opioid safety: is your patient at risk for respiratory depression?. Clin J Oncol Nurs 11 (2007) 293-296
34. Chelf J.H., Agre P., Axelrod A., et al. Cancer-related patient education: an overview of the last decade of evaluation and research. Oncol Nurs Forum 28 (2001) 1139-1147
35. Ward S., Hughes S., Donovan H., and Serlin R.C. Patient education in pain control. Support Care Cancer 9 (2001) 148-155